Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-000295
Filing Date
2023-01-03
Accepted
2023-01-03 17:05:20
Documents
1
Period of Report
2022-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4055
  Complete submission text file 0000899243-23-000295.txt   5650
Mailing Address C/O AKERO THERAPEUTICS, INC. 170 HARBOR WAY 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
White William Richard (Reporting) CIK: 0001778739 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39438 | Film No.: 23503094

Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Disc Medicine, Inc. (Issuer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations